共 50 条
Design, Synthesis, and Antitumor Activity Evaluation of Artemisinin Bivalent Ligands
被引:1
|作者:
Zhong, Hui
[1
]
Jiang, Qi
[1
]
Wu, Cong
[1
]
Yu, Huanghe
[1
,2
]
Li, Bin
[1
,2
]
Zhou, Xudong
[1
,2
]
Fu, Ronggeng
[1
]
Wang, Wei
[1
,2
]
Sheng, Wenbing
[1
,2
]
机构:
[1] Hunan Univ Chinese Med, Sch Pharm, Changsha 410208, Peoples R China
[2] Hunan Univ Chinese Med, TCM & Ethnomed Innovat & Dev Int Lab, Changsha 410208, Peoples R China
来源:
MOLECULES
|
2024年
/
29卷
/
02期
关键词:
artemisinin;
bivalent ligands;
multi-target molecular docking;
antitumor target protein;
antitumor activity;
BRIDGED PORPHYRINS;
IN-VITRO;
CANCER;
ANTIMALARIAL;
DERIVATIVES;
POTENT;
DIMERS;
BCL-2;
MECHANISMS;
EXPRESSION;
D O I:
10.3390/molecules29020409
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Five artemisinin bivalent ligands molecules 4a-4e were designed, synthesized, and confirmed by 1H NMR, 13C NMR, and low-resolution mass spectrometry, and the bioactivities of the target compounds were investigated against four human tumor cell lines in vitro, including BGC-823, HepG-2, MCF-7, and HCT-116. The results showed 4a, 4d, and 4e exhibited significantly tumor cell inhibitory activity compared with the artemisinin and dihydroartemisinin; compound 4e has good biological activity inhibiting BGC-823 with an IC50 value of 8.30 mu mol/L. Then, the good correlations with biological results were validated by molecular docking through the established bivalent ligands multi-target model, which showed that 4e could bind well with the antitumor protein MMP-9.
引用
收藏
页数:14
相关论文